Literature DB >> 11000214

Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

H Nakai1, T A Storm, M A Kay.   

Abstract

Recombinant adeno-associated virus (rAAV) vectors stably transduce hepatocytes in experimental animals. Following portal-vein administration of rAAV vectors in vivo, single-stranded (ss) rAAV genomes become double stranded (ds), circularized, and/or concatemerized concomitant with a slow rise and, eventually, steady-state levels of transgene expression. Over time, at least some of the stabilized genomes become integrated into mouse chromosomal DNA. The mechanism(s) of formation of stable ds rAAV genomes from input ss DNA molecules has not been delineated, although second-strand synthesis and genome amplification by a rolling-circle model has been proposed. To begin to delineate a mechanism, we produced rAAV vectors in the presence of bacterial PaeR7 or Dam methyltransferase or constructed rAAV vectors labeled with different restriction enzyme recognition sites and introduced them into mouse hepatocytes in vivo. A series of molecular analyses demonstrated that second-strand synthesis and rolling-circle replication did not appear to be the major processes involved in the formation of stable ds rAAV genomes. Rather, recruitment of complementary plus and minus ss genomes and subsequent random head-to-head, head-to-tail, and tail-to-tail intermolecular joining were primarily responsible for the formation of ds vector genomes. These findings contrast with the previously described mechanism(s) of transduction based on in vitro studies. Understanding the mechanistic process responsible for vector transduction may allow the development of new strategies for improving rAAV-mediated gene transfer in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000214      PMCID: PMC112374          DOI: 10.1128/jvi.74.20.9451-9463.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination.

Authors:  J Yang; W Zhou; Y Zhang; T Zidon; T Ritchie; J F Engelhardt
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Structural analysis of adeno-associated virus transduction circular intermediates.

Authors:  D Duan; Z Yan; Y Yue; J F Engelhardt
Journal:  Virology       Date:  1999-08-15       Impact factor: 3.616

Review 3.  Adeno-associated virus vectors and hematology.

Authors:  D W Russell; M A Kay
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

4.  Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication.

Authors:  J E Nelson; M A Kay
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.

Authors:  S R Yant; L Meuse; W Chiu; Z Ivics; Z Izsvak; M A Kay
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

6.  Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  Nat Biotechnol       Date:  2000-05       Impact factor: 54.908

7.  Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein.

Authors:  M Burton; H Nakai; P Colosi; J Cunningham; R Mitchell; L Couto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

8.  Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver.

Authors:  H Nakai; Y Iwaki; M A Kay; L B Couto
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

9.  Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction.

Authors:  C H Miao; H Nakai; A R Thompson; T A Storm; W Chiu; R O Snyder; M A Kay
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

10.  Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression.

Authors:  D Duan; P Sharma; L Dudus; Y Zhang; S Sanlioglu; Z Yan; Y Yue; Y Ye; R Lester; J Yang; K J Fisher; J F Engelhardt
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  67 in total

1.  Genetic fate of recombinant adeno-associated virus vector genomes in muscle.

Authors:  Bruce C Schnepp; K Reed Clark; Dori L Klemanski; Christina A Pacak; Philip R Johnson
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Adeno-associated viruses undergo substantial evolution in primates during natural infections.

Authors:  Guangping Gao; Mauricio R Alvira; Suryanarayan Somanathan; You Lu; Luk H Vandenberghe; John J Rux; Roberto Calcedo; Julio Sanmiguel; Zahra Abbas; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

3.  Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors.

Authors:  Clare E Thomas; Theresa A Storm; Zan Huang; Mark A Kay
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

4.  Induced pluripotent stem cell clones reprogrammed via recombinant adeno-associated virus-mediated transduction contain integrated vector sequences.

Authors:  J Weltner; A Anisimov; K Alitalo; T Otonkoski; R Trokovic
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

5.  Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver.

Authors:  Ali Nowrouzi; Magalie Penaud-Budloo; Christine Kaeppel; Uwe Appelt; Caroline Le Guiner; Philippe Moullier; Christof von Kalle; Richard O Snyder; Manfred Schmidt
Journal:  Mol Ther       Date:  2012-03-27       Impact factor: 11.454

Review 6.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

Review 7.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

8.  Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells.

Authors:  Masashi Urabe; Takayo Nakakura; Ke-Qin Xin; Yoko Obara; Hiroaki Mizukami; Akihiro Kume; Robert M Kotin; Keiya Ozawa
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  Large-scale analysis of adeno-associated virus vector integration sites in normal human cells.

Authors:  Daniel G Miller; Grant D Trobridge; Lisa M Petek; Michael A Jacobs; Rajinder Kaul; David W Russell
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.

Authors:  Afrooz Rashnonejad; Gholamhossein Amini Chermahini; Cumhur Gündüz; Hüseyin Onay; Ayça Aykut; Burak Durmaz; Meral Baka; Qin Su; Guangping Gao; Ferda Özkınay
Journal:  Mol Ther       Date:  2019-08-31       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.